These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2709713)
1. [Use of arachidene and alpha-tocopherol in the preoperative management of patients with peptic ulcer]. Tabutsadze TU Khirurgiia (Mosk); 1989 Feb; (2):44-7. PubMed ID: 2709713 [TBL] [Abstract][Full Text] [Related]
2. [Effect of vagotomy, alpha-tocopherol and arachidene on the synthesis of prostaglandins (E, F2alpha), thromboxane and prostacyclin in different areas of the mucous membrane of the gastroduodenal zone in rats with experimental ulcers]. Morenkova SA; Tabutsadze TU; Fedorova LM; Miagkova GI; Evstigneeva RP Patol Fiziol Eksp Ter; 1987; (5):62-6. PubMed ID: 3481066 [No Abstract] [Full Text] [Related]
3. [Effect of vagotomy, alpha-tocopherol and arachidene on lipid peroxidation in various areas of the gastroduodenal zone in rats with experimental peptic ulcer]. Morenkova SA; Tabutsadze TU; Fedorova LM; Miagkova GI; Evstigneeva RP Biull Eksp Biol Med; 1987 May; 103(5):532-4. PubMed ID: 3593916 [TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of the effect of vagotomy, antioxidants and arachidene on the glutathione and glutathione-dependent enzyme system in experimental duodenal ulcer]. Morenkova SA; Tabutsadze TU; Masenko VP; Miagkova GI; Evstigneeva VG Patol Fiziol Eksp Ter; 1987; (6):76-9. PubMed ID: 2832811 [No Abstract] [Full Text] [Related]
5. [Is gastric and duodenal ulcer drug-treatable or surgical disease?]. Fedele E Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869 [No Abstract] [Full Text] [Related]
6. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer]. Pal'tsev AI; Maslennikova TA Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582 [No Abstract] [Full Text] [Related]
7. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy]. Esedov EM; Muradova VR; Mamaev SN Ter Arkh; 1999; 71(2):19-22. PubMed ID: 10222547 [TBL] [Abstract][Full Text] [Related]
8. [Cellular immunity of patients with peptic ulcer undergoing antiulcer therapy]. Komarov FI; Serebrianskaia MV; Pogromov AP Voen Med Zh; 1989 Dec; (12):23-7. PubMed ID: 2631406 [No Abstract] [Full Text] [Related]
9. [Effect of various types of vagotomy on prostaglandins (E, F2 alpha), thromboxane and prostacyclin synthesis in the mucosa of the gastroduodenal zone in experimental ulcer in the rat]. Morenkova SA; Tabutsadze TU; Fedorova LM Vopr Med Khim; 1988; 34(1):109-12. PubMed ID: 3285586 [TBL] [Abstract][Full Text] [Related]
10. [The clinico-endoscopic, psychological and physical characteristics of duodenal peptic ulcer patients using piracetam and aevit]. Pimenov LT; Balobanov VIu; Pushina LN; Shemiakina TV Ter Arkh; 1997; 69(2):10-3. PubMed ID: 9173565 [TBL] [Abstract][Full Text] [Related]
15. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149 [TBL] [Abstract][Full Text] [Related]
16. [Treatment tactics of the patients with gastroduodenal ulcer bleeding]. Vonokurov MM; Kapitonova MA Khirurgiia (Mosk); 2008; (2):33-6. PubMed ID: 18427490 [TBL] [Abstract][Full Text] [Related]
17. Antrectomy and gastroduodenostomy with or without vagotomy in peptic ulcer disease. A prospective study with a 5-year follow-up. Rehnberg O Acta Chir Scand Suppl; 1983; 515():1-63. PubMed ID: 6579806 [TBL] [Abstract][Full Text] [Related]
18. [Ulcer disease--the viewpoint of the internist]. Domschke W Verh Dtsch Ges Inn Med; 1986; 92():352-5. PubMed ID: 3811532 [No Abstract] [Full Text] [Related]
19. [Current status of the surgical therapy of peptic ulcer]. Speranza V Minerva Chir; 1987 Oct; 42(19):1473-7. PubMed ID: 3317118 [No Abstract] [Full Text] [Related]
20. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]